Tumor localization and biochemical response to cure in tumor-induced osteomalacia

Journal of Bone and Mineral Research

Volumn 28, Issue 6, 2013, Pages 1386-1398

  Chong, William H ^a   Andreopoulou, Panagiota ^a,b   Chen, Clara C ^c   Reynolds, James ^c   Guthrie, Lori ^a   Kelly, Marilyn ^a   Gafni, Rachel I ^a   Bhattacharyya, Nisan ^a   Boyce, Alison M ^a,d   El Maouche, Diala ^a   Crespo, Diana Ovejero ^a   Sherry, Richard ^e   Chang, Richard ^c   Wodajo, Felasfa M ^f   Kletter, Gad B ^g   Dwyer, Andrew ^c   Collins, Michael T ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f VIRGINIA HOSPITAL CENTER   (United States)

^g SWEDISH MEDICAL CENTER   (United States)

Author keywords

FGF23; HYPOPHOSPHATEMIA; MINERAL METABOLISM; OSTEOMALACIA; VITAMIN D

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE IN 111; PHOSPHOROUS ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FALSE POSITIVE RESULT; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; ONCOGENIC OSTEOMALACIA; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR SCINTISCANNING; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CALCITRIOL; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FEMALE; FIBROBLAST GROWTH FACTORS; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OCTREOTIDE; OSTEOMALACIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84878253507     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1881     Document Type: Article

References (20)

1. Chong WH, Molinolo AA, Chen CC, Collins MT., Tumor-induced osteomalacia. Endocr Relat Cancer. 2011; 18 (3): R53-77.
2. Jan de Beur SM., Tumor-induced osteomalacia. JAMA. 2005; 294 (10): 1260-7.
3. Drezner MK., Tumor-induced osteomalacia. Rev Endocr Metab Disord. 2001; 2 (2): 175-86.
4. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW., Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004; 28 (1): 1-30.
5. Duet M, Kerkeni S, Sfar R, Bazille C, Liote F, Orcel P., Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia. Clin Nucl Med. 2008; 33 (11): 752-6.
6. Dupond JL, Mahammedi H, Magy N, Blagosklonov O, Meaux-Ruault N, Kantelip B., Detection of a mesenchymal tumor responsible for hypophosphatemic osteomalacia using FDG-PET. Eur J Intern Med. 2005; 16 (6): 445-6.
7. Hesse E, Moessinger E, Rosenthal H, Laenger F, Brabant G, Petrich T, Gratz KF, Bastian L., Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res. 2007; 22 (1): 158-62.
8. von Falck C, Rodt T, Rosenthal H, Langer F, Goesling T, Knapp WH, Galanski M., (68)Ga-DOTANOC PET/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia. Eur J Nucl Med Mol Imaging. 2008; 35 (5): 1034.
9. Kimizuka T, Ozaki Y, Sumi Y., Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia. Ann Nucl Med. 2004; 18 (1): 63-7.
10. Lee HK, Sung WW, Solodnik P, Shimshi M., Bone scan in tumor-induced osteomalacia. J Nucl Med. 1995; 36 (2): 247-9.
11. Dissanayake AM, Wilson JL, Holdaway IM, Reid IR., Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J. 2003; 33 (12): 615-6.
12. Nasu T, Kurisu S, Matsuno S, Tatsumi K, Kakimoto T, Kobayashi M, Nakano Y, Wakasaki H, Furuta H, Nishi M, Sasaki H, Suzuki H, Ito N, Fukumoto S, Nanjo K., Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med. 2008; 47 (10): 957-61.
13. Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, Chang R, Collins MT., Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res. 2011; 26 (6): 1295-302.
14. Bhattacharyya N, Wiench M, Dumitrescu C, Connolly BM, Bugge TH, Patel HV, Gafni RI, Cherman N, Cho M, Hager GL, Collins MT., Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res. 2012; 27 (5): 1132-41.
15. Bergwitz C, Collins MT, Kamath RS, Rosenberg AE., Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia. N Engl J Med. 2011; 365 (17): 1625-35.
16. Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT., Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res. 2007; 22 (6): 931-7.
17. Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW., Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res. 2012; 27 (9): 1967-75.
18. Chong WH, Yavuz S, Patel SM, Chen CC, Collins MT., The importance of whole body imaging in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2011; 96 (12): 3599-600.
19. Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Juppner H., Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab. 2010; 95 (2): 578-85.
20. Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL., Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res. 1997; 12 (9): 1502-11.